Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,753,365
-$423,781 QoQ
Shares Held
6,166
-12.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHOREO, LLC holds $18,026,679 across 36 Biotechnology names. VRTX ranks #2 (15.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,175 | $4,771,052 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
6,166 | $2,753,365 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,711 | $896,988 | |
| 4 | INCY |
Incyte Corp
|
8,189 | $770,748 | |
| 5 | GMAB |
Genmab A/S
|
24,889 | $667,771 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
10,482 | $592,128 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,968 | $561,100 | |
| 8 | CELC |
Celcuity Inc.
|
4,895 | $558,715 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,753,365 | 6,166 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,177,146 | 7,008 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,292,660 | 5,854 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,828,355 | 6,353 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,099,454 | 6,393 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,453,248 | 6,092 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,761,645 | 5,938 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,037,994 | 4,348 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $204,824 | 490 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||